Magee Thomson Investment Partners’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Magee Thomson Investment Partners’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-49	Closed	-$1K	–	115
2016 Q4	$1K	Sell	49 -17	-26%	-$326	﹤0.01%	93
2016 Q3	$1K	Hold	66	–	–	﹤0.01%	90
2016 Q2	$1K	Sell	66 -223	-77%	-$3.84K	﹤0.01%	87
2016 Q1	$5K	Hold	289	–	–	﹤0.01%	50
2015 Q4	$5K	Hold	289	–	–	﹤0.01%	70
2015 Q3	$5K	Hold	289	–	–	﹤0.01%	65
2015 Q2	$8K	Buy	289 +43	+17%	+$1.09K	﹤0.01%	39
2015 Q1	$5K	Buy	+246	New	+$5.31K	﹤0.01%	73

Other funds holding ENTL

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

DGI

Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magee Thomson Investment Partners's ENTL Position: Q1 2017 in Review

Magee Thomson Investment Partners sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2017, closing a stake of 49 shares — an estimated $1K sold.

Magee Thomson Investment Partners first reported a position in ENTL in Q1 2015 and held it in 8 quarters. The position peaked at $8K in Q2 2015. 69 funds tracked by Wall St. Rank hold ENTL as of Q1 2017.

Magee Thomson Investment Partners reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
Magee Thomson Investment Partners sold 49 Entellus Medical, Inc. Common Stock shares in Q1 2017, an estimated $1K.
Magee Thomson Investment Partners first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 8 quarters.
Magee Thomson Investment Partners's Entellus Medical, Inc. Common Stock position peaked at $8K in Q2 2015.
69 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2017.

Based on Magee Thomson Investment Partners's 13F filing for Q1 2017, filed 21 Apr 2017.